(May 15, 2020, 1:05 PM EDT) -- SAN FRANCISCO — As proceedings prepare to get under way in Monsanto’s appeal of a $78,506,418.35 glyphosate cancer verdict, a source affiliated with the plaintiff told Mealey Publications on May 14 that a note on the docket suggests that the appeals court has already “moved past” questions regarding the adequacy of the science and whether the evidence was sufficient for a punitive damages award (DeWayne Johnson v. Monsanto Company, Nos. A155940 and A156706, Calif. App., 1st Dist.)....